Home›Search›Molecular Imaging and Radionuclide Therapy

Molecular Imaging and Radionuclide Therapy

Galenos Publishing House · Turkey · Est. 1989

ISSN2147-1959

SJR Q3✓ WOS ESCI✓ Scopus / SJR

Removed from DOAJ (2021-06-17). DOAJ's stated reason: Journal not adhering to Best practice. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.274

H-Indexi

SNIPi

0.278

Total Worksi

565

Total Citationsi

3,115

2yr Mean Citednessi

0.67

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Molecular Imaging and Radionuclide Therapy is a journal in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry, and radiobiology.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionTurkey

Primary Language—

1st Year Published1989

Annual Volume~ 55 articles / year

StatusActive (last: 2026)

Total Publications565

Publisher OrgGalenos Yayinevi

OA Since2010

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Galenos Publishing House

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2147-1959

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

215

2019

175

2020

167

2021

184

2022

130

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Radiology, Nuclear Medicine and ImagingQ3

Subject Classification

Web of Science Categories

Radiology, Nuclear Medicine & Medical Imaging

Scopus Categories

Radiology, Nuclear Medicine and Imaging

Research Topics (OpenAlex)

Medical Imaging Techniques and ApplicationsMedical Imaging and Pathology StudiesThyroid Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and ResearchRadiomics and Machine Learning in Medical ImagingCancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryThyroid Disorders and TreatmentsHematological disorders and diagnostics

Frequently asked questions about Molecular Imaging and Radionuclide Therapy

Is Molecular Imaging and Radionuclide Therapy a predatory journal?

Molecular Imaging and Radionuclide Therapy was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal not adhering to Best practice" (2021-06-17). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Molecular Imaging and Radionuclide Therapy?

Molecular Imaging and Radionuclide Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.67.

Is Molecular Imaging and Radionuclide Therapy indexed in Scopus and Web of Science?

Molecular Imaging and Radionuclide Therapy is indexed in Web of Science, Scopus.